Monitor the October 16 shareholder vote outcome and any further redemption withdrawals. The high redemption rate suggests limited public support for the extension, increasing the risk of liquidation if the deal is not consummated soon.
Price Chart
Executive Summary
Oaktree Acquisition Corp. III Life Sciences disclosed that 13,326,977 Class A ordinary shares were tendered for redemption ahead of the October 14, 2026 deadline, ahead of an October 16, 2026 shareholder vote on extending the deadline to complete a business combination. The sponsor will convert 4,798,758 Class B shares into Class A shares prior to the extension, waiving redemption rights on those shares. This filing signals significant shareholder redemptions that reduce trust assets available for a future deal.
Key Facts
- 13,326,977 Class A ordinary shares were tendered for redemption as of the October 14, 2026 deadline
- Post-redemption and conversion, OAC will have 11,254,791 Class A shares and 1,000 Class B shares outstanding
- Sponsor will convert 4,798,758 Class B shares into Class A shares on a one-for-one basis prior to extension effectiveness
- Sponsor waived redemption rights on the converted Class A shares and will hold 5,382,739 total Class A shares post-conversion
- Shareholder meeting to vote on extension is scheduled for October 16, 2026
Financial Impact
Approximately 13.3 million shares redeemed, representing a substantial portion of the public float; trust account will be reduced by the per-share redemption amount (not specified in filing).
Risk Factors
- High redemptions reduce trust cash available for a future business combination, potentially making a deal less attractive or requiring alternative financing
- If the extension proposal fails at the October 16 meeting, the SPAC may be forced to liquidate
- Shareholders may still withdraw redemptions before the meeting, but the current level indicates significant cash outflow
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-422263 |
| Document: 0001193125-26-422263-index-headers.html | 0001193125-26-422263 |
| Document: 0001193125-26-422263-index.html | 0001193125-26-422263 |
| Document: 0001193125-26-422263.txt | 0001193125-26-422263 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+1 | — | — |
Oct 16, 2026 10d ago | DEFA14A | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.71 (−0.09%) |
Oct 16, 2026 10d ago | 8-K | $10.70 $10.65 | ▲ +0.47% | ▲ +0.89% | $10.71 (−0.09%) |
Oct 15, 2026 11d ago | DEFA14A | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.71 (−0.56%) |
Oct 15, 2026 11d ago | 8-K | $10.65 $10.70 | ▼ −0.47% | ▼ −1.58% | $10.71 (−0.56%) |
Oct 2, 2026 24d ago | DEF 14A | $10.76 $10.76 | · 0.00% | ▼ −0.55% | $10.71 (−0.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers